当前位置:首页 - 行情中心 - 以岭药业(002603) - 财务分析

以岭药业

(002603)

  

流通市值:241.27亿  总市值:292.87亿
流通股本:13.76亿   总股本:16.71亿

以岭药业(002603)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.49亿元,每股收益0.33元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1148564.23万元,未分配利润655965.21万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1661408.47万元,负债512844.24万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入6,365,441,001.174,604,485,816.892,522,632,691.8410,318,312,851.48
营业总成本5,723,859,252.053,978,871,341.642,163,331,046.018,719,196,279.82
营业利润703,133,763.23670,958,832.67391,394,262.21,779,827,529.25
利润总额672,108,390.61643,322,075.42368,455,607.481,684,211,359.6
净利润549,086,852.74526,626,374.89301,919,698.611,344,302,675.78
其他综合收益551,883.7520,576.61-33,169.55604,594.09
综合收益总额549,638,736.49526,646,951.5301,886,529.061,344,907,269.87
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计6,183,574,663.116,537,412,403.86,656,361,082.976,543,745,737.68
非流动资产合计10,430,510,047.8710,414,113,796.3110,472,109,702.5710,435,580,799.21
资产总计16,614,084,710.9816,951,526,200.1117,128,470,785.5416,979,326,536.89
流动负债合计3,937,753,312.34,374,366,278.14,285,574,207.764,446,701,155.56
非流动负债合计1,190,689,0751,113,729,383.341,103,014,848.751,094,630,181.36
负债合计5,128,442,387.35,488,095,661.445,388,589,056.515,541,331,336.92
归属于母公司股东权益合计11,503,839,430.8711,478,988,389.4711,753,617,065.711,449,722,316.51
股东权益合计11,485,642,323.6811,463,430,538.6711,739,881,729.0311,437,995,199.97
负债和股东权益合计16,614,084,710.9816,951,526,200.1117,128,470,785.5416,979,326,536.89
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计5,600,361,187.313,986,854,237.471,991,079,544.749,543,446,367.82
经营活动现金流出小计5,277,731,356.233,722,687,357.561,874,074,272.789,387,988,934.03
经营活动产生的现金流量净额322,629,831.08264,166,879.91117,005,271.96155,457,433.79
投资活动现金流入小计2,146,354,236.062,006,096,063.161,481,130,024.343,726,023,454.91
投资活动现金流出小计2,146,469,910.381,867,976,571.021,403,825,146.614,625,241,328.81
投资活动产生的现金流量净额-115,674.32138,119,492.1477,304,877.73-899,217,873.9
筹资活动现金流入小计1,047,716,733.33677,716,733.33480,526,733.331,700,000,000
筹资活动现金流出小计1,355,605,763.36766,595,483.81410,505,105.191,920,594,981.44
筹资活动产生的现金流量净额-307,889,030.03-88,878,750.4870,021,628.14-220,594,981.44
汇率变动对现金及现金等价物的影响-19,813.0145,043.945,380.45326,399.88
现金及现金等价物净增加额14,605,313.72313,452,665.51264,337,158.28-964,029,021.67
期末现金及现金等价物余额861,239,443.21,160,086,794.991,110,971,287.76846,634,129.48
最新报告期:2024-11-07
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国盛证券张金洋,胡偌碧0.490.650.752024-11-07
华创证券郑辰0.540.650.782024-11-04
华泰证券代雯,张云逸0.810.931.062024-10-29
平安证券叶寅0.690.800.962024-08-30
国联证券郑薇0.901.101.202024-08-29
TOP↑